Atezolizumab-induced myositis in a patient with small-cell lung cancer.

导出 LinkOut

翻译打印收藏纠错

第一作者： Elif,Sahin

第一单位： Department of Medical Oncology, Kocaeli University Faculty of Medicine, Izmit, Turkey.

作者： Elif,Sahin ^[1] ; Devrim,Cabuk ^[1] ; Fatma,Tuncer Kuru ^[2] ; Ayten,Yazici ^[2]

作者单位： Department of Medical Oncology, Kocaeli University Faculty of Medicine, Izmit, Turkey. ^[1] Department of Rheumatology, Kocaeli University Faculty of Medicine, Izmit, Turkey. ^[2]

关键词 Myositis immune checkpoint inhibitors immune-related adverse events

主题词人类(Humans);肺肿瘤(Lung Neoplasms);肌炎(Myositis);小细胞肺癌(Small Cell Lung Carcinoma)

DOI 10.1177/10781552231203190

PMID 37750202

发布时间 2024-01-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Journal of oncology pharmacy practice

2024年30卷1期

220-224页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Atezolizumab-induced myositis in a patient with small-cell lung cancer.

Journal of oncology pharmacy practice

相似文献

Journal of oncology pharmacy practice

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Atezolizumab-induced myositis in a patient with small-cell lung cancer.

Journal of oncology pharmacy practice

相似文献

Journal of oncology pharmacy practice

相关期刊

检索历史清除